Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.51 - $3.8 $30,872 - $46,740
12,300 New
12,300 $44,000
Q2 2022

Aug 15, 2022

SELL
$1.59 - $2.7 $31,482 - $53,460
-19,800 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$2.02 - $3.92 $39,996 - $77,616
19,800 New
19,800 $51,000
Q4 2021

Feb 14, 2022

SELL
$3.74 - $6.7 $62,084 - $111,220
-16,600 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$6.05 - $10.41 $24,200 - $41,640
4,000 Added 31.75%
16,600 $100,000
Q1 2021

May 14, 2021

BUY
$4.59 - $18.74 $57,834 - $236,123
12,600 New
12,600 $111,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $360M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.